ÂÜÀòÂÒÂ×

Bobby Stutz is a seasoned professional with extensive experience in business development and scientific affairs within the biomedical and healthcare industries. Currently serving as Senior Director of Business Development at WCG since November 2020, Bobby focuses on enhancing the quality and efficiency of clinical trials for biopharmaceutical companies and CROs. Bobby previously held multiple roles at ATCOR from December 2006 to November 2020, including Director of Pharmaceutical Markets & Scientific Affairs, where responsibilities encompassed business development, client management, and technical support for the SphygmoCor® technology. An educational background in Biomedical Engineering includes both a Master’s and Bachelor’s degree from The Catholic University of America.